PTGX Stock Analysis: Buy, Sell, or Hold?
PTGX - Protagonist Therapeutics, Inc
$99.87
0.90 (0.91%)
▲
5d:
+1.35%
30d:
+8.46%
90d:
+12.49%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
PTGX is down 3.6% this week, but smart money is accumulating calls. Top strike: $90 2026-04-17 with 2,107 OI. Call ratio: 100% View Scanner →
Strength: 6.8/10
Get Alerted When PTGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PTGX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: PTGX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: PTGX is currently trading at $99.87, which is considered slightly high relative to its 30-day fair value range of $88.89 to $100.04. From a valuation perspective, the stock is trading at a discount (Forward PE: -227.9) compared to its historical average (83.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PTGX is in a uptrend. Immediate support is located at $90.58, while resistance sits at $105.69.
Market Sentiment: PTGX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $112.42 (+13.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PTGX is in a uptrend. Immediate support is located at $90.58, while resistance sits at $105.69.
Market Sentiment: PTGX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $112.42 (+13.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$88.89 -
$100.04
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
82.7%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($112.42)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Fair Price Analysis
30-Day Fair Range
$88.89 -
$100.04
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$5.83
(5.8%)
Support & Resistance Levels
Support Level
$90.58
Resistance Level
$105.69
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-227.94
Wall Street Target
$112.42
(+13.6%)
Revenue Growth (YoY)
-95.6%
Earnings Growth (YoY)
351.3%
Profit Margin
-282.8%
PE vs Historical
-227.9 vs 83.6
CHEAP
Share & Embed Analysis
Last updated: March 30, 2026 4:27 PM ET
Data refreshes hourly during market hours. Next update: 5:27 PM
Data refreshes hourly during market hours. Next update: 5:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Lewis T Williams
SELL
18000 shares
2026-02-17
William D Waddill
SELL
20000 shares
2026-02-06
Arturo Md Molina
SELL
5000 shares
2026-01-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 51 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 44 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 54 HOLD |
Advanced PTGX Option Strategies
Professional options setups generated by AI based on today's PTGX price and gamma walls.
